Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human somatostatin receptor type 2
Assay data:2 Activity ≤ 1 µM, 3 Tested
SummaryRelated BioAssays by Target
Binding affinity to human somatostatin receptor type 2
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of human SSTR2
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Agonist activity at rat SST2 receptor
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Agonist activity at human SST2 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay
Assay data:30 Active, 8 Activity ≤ 1 nM, 30 Activity ≤ 1 µM, 30 Tested
Binding Assay from US Patent US11834435: "SSTR4 agonist salts"
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Displacement of [125I]-Tyr-SRIF 14 from human SST2A receptor expressed in membrane measured after 90 mins by gamma counting analysis
Assay data:21 Active, 1 Activity ≤ 1 µM, 59 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Agonist activity at rat SST5
Assay data:2 Active, 2 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Agonist activity at human SST2
Assay data:2 Active, 3 Activity ≤ 1 µM, 3 Tested
Binding affinity to mouse SST2 expressed in mouse pheochromocytoma cells assessed as maximum binding capacity for 1 hr by Nanodrop spectrophotometric analysis
Assay data:8 Tested
SummaryPubMed CitationRelated BioAssays by Target
Binding affinity to mouse SST2 expressed in mouse pheochromocytoma cells assessed as dissociation constant for 1 hr by nanodrop spectrophotometric analysis
Assay data:7 Active, 7 Activity ≤ 1 µM, 8 Tested
cAMP Assay of SSTR2 from US Patent US11186590: "Somatostatin modulators and uses thereof"
Assay data:21 Active, 23 Activity ≤ 1 nM, 23 Activity ≤ 1 µM, 23 Tested
Radioligand Binding Assay from US Patent US11136312: "3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof"
Assay data:71 Active, 6 Activity ≤ 1 nM, 70 Activity ≤ 1 µM, 71 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Radioligand Binding Assays from US Patent US10675268: "Somatostatin receptor subtype 4 (SSTR4) agonists"
Assay data:20 Active, 20 Activity ≤ 1 µM, 20 Tested
cAMP Assay from US Patent US10696689: "Somatostatin modulators and uses thereof"
cAMP Assay from US Patent US10597377: "Somatostatin modulators and uses thereof"
Assay data:257 Active, 258 Activity ≤ 1 µM, 258 Tested
Radioligand Binding Assays from US Patent US10577336: "Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists"
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
cAMP Assay from US Patent US10464918: "Process of making somatostatin modulators"
Assay data:11 Active, 11 Activity ≤ 1 µM, 11 Tested
Radioligand Binding Assay from US Patent US8952128: "Somatostatin-dopamine chimeric analogs"
Assay data:49 Active, 42 Activity ≤ 1 nM, 49 Activity ≤ 1 µM, 49 Tested
cAMP Assay from US Patent US10351547: "Somatostatin modulators and uses thereof"
Assay data:262 Active, 263 Activity ≤ 1 µM, 263 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on